Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( May )
Should I stay or should I go?
There are no easy answers when it comes to timing a job move, says Tim Ewbank, but you can make yourself a more attractive candidate for that next job.(more)
Regional research still hampered by cross-border differences
In the age of the Euro-trial, patients are not well served by processes that add unnecessary delays to the development of new medicines, says Les Rose(more)
A sea of paperwork or business as usual?
Steven Gray looks ahead to the soon-to-be finalised 2008 ABPI Code of Practice and how it will affect everyday practice in the UK industry(more)
Pharmafocus.comNews Headlines Register for News Alert
News for March 2008
Previous Months: April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Boehringer Ingelheim's Pradaxa approved in Europe
Anti-clotting pill will be first launched in the UK and Germany..(more)

 Accomplia gains limited NICE approval
Sanofi-Aventis' pill only recommended if other anti-obesity drugs fail..(more)

 Merck's hepatitis B vaccine trial on hold
FDA takes step after a patient develops a rare but serious blood condition..(more)

 Gardasil licence extension gets priority FDA review
If successful Merck's vaccine could win a further advantage over GSK rival..(more)

 Pharming's orphan drug receives second setback in Europe
Dutch biotech will re-file for approval with additional data..(more)

 GSK consolidates Cervarix PR ahead of crucial vaccine decision
Agency wins consumer and press accounts..(more)

 Early access to experimental drugs for terminally ill
Network of centres to speed up development of new cancer treatments..(more)

 NHS Trusts to promote their services to the public
NHS-branded adverts will run in regional media..(more)

 Latest news from Datamonitor
Big pharma and emerging markets..(more)

 Nexium and Seroquel face US generic fight
Two of AstraZeneca's biggest brands attacked..(more)

 Latest news from Datamonitor
The cost of licensing..(more)

 AZ and Silence to collaborate on gene technology
Tie-up aimed at improving 'gene silencing' treatments..(more)

 Industry doubts government commitment to innovation
ABPI says NHS not set up meet demands of new white paper..(more)

 Side-effect caution to delay Tyverb
Small number of trial patients suffered liver side-effects..(more)

 Manchester selected for translational medicine centre
Biomedical Research Centre will help speed development of new treatments..(more)

 Workshops to bring together industry and NHS researchers
ABPI and Department of Health collaborate on new initiatives..(more)

 Spend NHS surplus on out-of-hours, say primary care leaders
NHS Alliance calls for investment in services to make out-of-hours agreement work..(more)

 Celgene buys up Pharmion
Acquisition gives US biopharma company new anaemia treatment..(more)

 Practice based commissioning and NICE workshops launched
Regional events to explore impact of PBC on NICE guidance uptake..(more)

 Lilly decision spells end for inhaled insulin
Doubts about commercial potential force halt to AIR insulin..(more)

 Abbott to work on Tarceva diagnostic
Will collaborate with Genentech, Roche and OSI Pharmaceuticals..(more)

 Latest news from Datamonitor
Type 2 diabetes driving epidemic..(more)

 Diabetes nurses would cut emergency admissions
Proactive care could help improve patient care and save NHS money..(more)

 NICE's approach to benefits and costs to be reviewed
Industry hopes discussions will lead to wider benefits of medicines being taken into account..(more)

 Frontline doctor to lead UK diabetes strategy
Dr Rowan Hillson becomes new diabetes 'czar'..(more)

 GPs reluctantly agree to extend hours
Surgeries to open on evenings and weekends..(more)

 Efexor successor approved in US
FDA gives green light to Pristiq as generic competition for Efexor looms..(more)

 Renovo wounded by cosmetic drug setback
Company will pursue alternative indication for Juvista..(more)

 New laws will oblige pharma to release data
Changes follow MHRA investigation of GSK's Seroxat..(more)

 Latest news from Datamonitor
Company news roundup..(more)

 GSK abandons malaria drugs
Lapdap and Dacart hit by safety concerns ..(more)

 Avastin receives surprise FDA approval
US regulator grants licence for first-line treatment of breast cancer..(more)

 FDA rejects long-acting version of Zyprexa
Setback for Lilly's best-selling atypical antipsychotic..(more)

 Government remains tight-lipped on PPRS
Refuses to comment on speculation pricing system will be scrapped..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.